概述

  • 产品名称Anti-IPO 38抗体[IPO-38]
    参阅全部 IPO 38 一抗
  • 描述
    小鼠单克隆抗体[IPO-38] to IPO 38
  • 经测试应用适用于: ELISA, IHC-P, IHC-Fr, IP, WBmore details
  • 种属反应性
    与反应: Human
  • 免疫原

    A BALB/c mouse was immunized with spleen cells of a human patient with hairy cell leukemia.

性能

  • 形式Liquid
  • 存放说明Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • 存储溶液pH: 7.20
    Preservative: 0.01% Sodium azide
    Constituents: 0.42% Potassium phosphate, 2.92% Sodium chloride
  • Concentration information loading...
  • 纯度Protein A purified
  • 纯化说明This protein A purified mouse monoclonal antibody reacts with a 14 -16 kDa protein as demonstrated by western blot analysis on the Raji cell line. This antigen was detected after 12 h of PHA-induced activation in the early G1 phase but absent in non-stimulated lymphocytes. Cross reactivity is likely to occur with mouse and rat. Reactivity with other sources has not been determined.
  • 克隆单克隆
  • 克隆编号IPO-38
  • 同种型IgM
  • 轻链类型kappa
  • 研究领域

应用

Our Abpromise guarantee covers the use of ab1045 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
ELISA 1/1000.
IHC-P 1/50 - 1/100.
IHC-Fr Use at an assay dependent dilution.
IP Use at an assay dependent dilution.
WB 1/50 - 1/100.

靶标

  • 相关性IPO-38 antigen is present in the nuclei of proliferating cells such as Hodgkin's disease and non-Hodgkin's lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO-38 can be a useful marker of cell proliferation during monitoring of tumor progression.

Anti-IPO 38 antibody [IPO-38] (ab1045)参考文献

This product has been referenced in:
  • Mikhalap SV  et al. Monoclonal antibody IPO-38 recognizes a novel nuclear antigen of proliferating cells. In Leucocyte Typing VI edited by Kishimoto T et al. Garland Publishing, Inc. New York & London. :609-610 (1997). Read more (PubMed: ) »
  • Sidorenko SP  et al. Experim. Oncol. 16:145-150 (1994). Read more (PubMed: ) »

See all 3 Publications for this product

Product Wall

There are currently no Abreviews or Questions for ab1045.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"